Texas 2017 - 85th Regular

Texas House Bill HB3304 Compare Versions

OldNewDifferences
11 85R12889 LED-D
2- By: King of Hemphill, Kacal H.B. No. 3304
2+ By: King of Hemphill H.B. No. 3304
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to health benefit plan coverage for ovarian cancer testing
88 and screening.
99 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1010 SECTION 1. Section 1370.003(b), Insurance Code, is amended
1111 to read as follows:
1212 (b) Coverage required under this section includes at a
1313 minimum:
1414 (1) a CA 125 blood test; [and]
1515 (2) a conventional Pap smear screening or a screening
1616 using liquid-based cytology methods, as approved by the United
1717 States Food and Drug Administration, alone or in combination with a
1818 test approved by the United States Food and Drug Administration for
1919 the detection of the human papillomavirus; and
2020 (3) any other test or screening approved by the United
2121 States Food and Drug Administration for the detection of ovarian
2222 cancer.
2323 SECTION 2. Section 1370.003, Insurance Code, as amended by
2424 this Act, applies only to a health benefit plan delivered, issued
2525 for delivery, or renewed on or after January 1, 2018. A health
2626 benefit plan delivered, issued for delivery, or renewed before
2727 January 1, 2018, is governed by the law as it existed immediately
2828 before the effective date of this Act, and that law is continued in
2929 effect for that purpose.
3030 SECTION 3. This Act takes effect September 1, 2017.